TL;DR
This systematic review and meta-analysis compares laparoscopy-assisted living donor hepatectomy (LADH) with traditional open donor hepatectomy (ODH). The findings suggest LADH is a safe and effective alternative, demonstrating significantly less blood loss and fewer postoperative complications, particularly for left lobe resections.
What Problem Does This Paper Address?
Liver transplantation is a life-saving procedure, but the availability of deceased donor organs is a significant limitation. Living donor liver transplantation (LDLT) offers a crucial alternative, but the safety and well-being of the healthy living donor are paramount. Traditionally, open hepatectomy (ODH) has been the standard for obtaining liver grafts from living donors. However, with the increasing adoption of minimally invasive techniques in surgery, there's a growing interest in laparoscopy-assisted living donor hepatectomy (LADH) as a potentially less morbid approach. The challenge lies in definitively comparing the efficacy, safety, and donor outcomes of LADH versus ODH to guide clinical practice and patient selection.
Methods
The authors conducted a systematic literature search across major databases (PubMed, Embase, Cochrane Library, Web of Science) to identify relevant studies comparing LADH and ODH for living liver donation. They included studies that were prospective or retrospective case series, excluding case reports, letters, reviews, and studies without control groups or incomplete data. Data extraction and quality assessment were performed independently by two investigators using the Newcastle-Ottawa Quality Assessment Scale (NOS). A meta-analysis was then performed using Review Manager Version 5.3 to pool data and calculate risk ratios (RR) for dichotomous variables and weighted mean differences (WMD) or standard mean differences (SMD) for continuous variables, all with 95% confidence intervals (CI). Subgroup analyses were conducted for right lobe (RH) and left lobe (LH) hepatectomies.
Datasets
This paper is a systematic review and meta-analysis, meaning it synthesizes data from existing published studies. It does not introduce new datasets or benchmarks. The "dataset" for this study comprises the data extracted from nine eligible studies that met the inclusion criteria, totaling 979 patients (309 in LADH and 670 in ODH).
Key Insights and Ideas
- Reduced Blood Loss is a Major Win: The most striking finding is the significant reduction in intraoperative blood loss with LADH. This is a critical factor for donor safety and recovery.
- Fewer Postoperative Complications, Especially for Left Lobe: LADH appears to lead to fewer overall postoperative complications, with a particularly strong benefit observed in left lobe hepatectomies. This suggests LADH might be especially advantageous when smaller portions of the liver are removed.
- No Compromise on Donor Safety: The study found no significant difference in major complications or mortality between LADH and ODH, reinforcing LADH's safety profile.
- Analgesic Use is Lower: Donors undergoing LADH required less postoperative analgesic use, hinting at reduced pain and improved comfort.
- Operation Time and Hospital Stay are Comparable: While LADH might have a slightly longer operative time (though not statistically significant in this analysis), hospital stays were similar between the two approaches. This suggests that any extra time in surgery doesn't translate to a longer recovery period.
Key Results
- Blood Loss: LADH was associated with significantly less intraoperative blood loss (WMD = -59.92 ml; 95% CI: -94.58~-25.27, P = 0.0007).
- Postoperative Complications: LADH showed a reduced rate of postoperative complications (RR = 0.70, 95% CI: 0.51~0.94, P = 0.02). This benefit was more pronounced in left lobe hepatectomies (RR = 0.43, 95% CI: 0.23~0.79, P = 0.007).
- Analgesic Use: LADH was associated with significantly less analgesic use (SMD = -0.22; 95% CI: -0.44~-0.11, P = 0.04).
- Operation Time: LADH tended to have a longer operation time, but this did not reach statistical significance (WMD = 24.85 min; 95% CI: -3.01~52.78, P = 0.08).
- Hospital Stay: Length of hospital stay was similar between LADH and ODH (WMD = -0.47 d; 95% CI: -1.78~0.83, P = 0.47).
- Transfusion Rates: Similar transfusion rates were observed between the groups (RR = 0.82; 95% CI: 0.24~3.12, P = 0.82).
- Graft Weight: No difference was found in graft weights (WMD = 7.31 g; 95% CI: -23.45~38.07, P = 0.64).
Limitations and Future Work
The authors acknowledge several limitations. Firstly, no randomized controlled trials were identified, meaning the included studies were primarily observational (case series). This introduces potential biases. Secondly, there was significant heterogeneity observed in some analyses, which they attribute to differences in study designs, participant numbers, donor characteristics, surgical techniques, and the fact that some data were estimated from median and range. They also note that the subgroup analysis for left hepatectomy had a small case volume.
Future work should focus on larger, prospective studies and randomized trials to further solidify these findings and provide more definitive evidence. Continued research is needed to fully understand the long-term outcomes and cost-effectiveness of LADH compared to ODH.
Summary updated